Sydney Patient & Carer Education Day
Hear from a world expert on Non - Hodgkin Follicular Lymphoma - Professor Mathias Rummel.
When - Saturday 30th March, 2019
Where - Saxons Education Centre, Level 10, 10 Barrack St, Sydney NSW 2000
The presentation focused on:
- Current frontline and relapsed treatments for follicular lymphoma
- What is new for follicular lymphoma
- Clinical Trials
- Your Questions Answered
About Professor Mathias Rummel
Rummel, MD, is a Professor of Medicine and is the director of the Department
for Haematology at the Clinic for Haematology and Medical Oncology at the
in Giessen, Germany.
current research focuses on novel treatment approaches in haematological
malignancies, most notably Follicular Lymphoma, Mantle Cell Lymphoma, Waldenstrom’s
Macroglobulinemia and other indolent lymphomas as well as Chronic Lymphocytic
Leukemia (CLL), Hairy Cell Leukemia and also in the non-malignant haematological
disorder Immune Thrombocytopenia (ITP).
He is the
chair of the large cooperative German Study group indolent Lymphomas (StiL)
with more than 220 study sites in Germany and Austria and is the principal investigator
of several on-going clinical protocols, in particular of Investigator Initiated
Rummel is actively involved in a number of professional scientific societies, including
the American Society of Haematology (ASH), American Society of Clinical
Oncology (ASCO), the European Society for Medical Oncology (ESMO), the European
(EHA), and the German Society of Haematology and Oncology (DGHO). He is the
principal investigator of many clinical trials in Leukemias, Lymphomas, Hairy
Cell Leukemia, and Immune Thrombocytopenia (ITP), and has published several
book chapters and papers in peer reviewed scientific journals.